Folate-conjugated and pH-responsive polymeric micelles for target-cell-specific anticancer drug delivery

Acta Biomater. 2017 Sep 15:60:244-255. doi: 10.1016/j.actbio.2017.07.018. Epub 2017 Jul 14.

Abstract

In this study, we developed a folate (FA)-conjugated and pH-responsive active targeting micellar system for anti-cancer drug delivery. In this system, FA was attached to the terminal of the hydrophilic segment of poly(lactic acid)-poly(L-lysine) (PLA-PLL), and PLL was modified by a citric acid group. The FA receptor-mediated active targeting and electrostatic interaction between micelles and cell membrane due to a negative-to-positive charge reversal was combined in one micellar anti-cancer drug delivery system to enhance the tumour targeting and cellular internalisation of micelles. In vitro and in vivo anti-cancer studies demonstrated that the doxorubicin-loaded, FA-conjugated and pH-responsive polymeric micelles possess an enhanced and effective cancer efficiency.

Statement of significance: Negatively charged nano-carriers prolonged anti-cancer drugs' blood circulation. However it is difficult to be internalised. Therefore, a negative-to-positive charged micelle surface could improve selectivity for tumour cells and increase uptake chance. In this study, we developed a folate (FA)-conjugated and pH-responsive active targeting micellar system for anti-cancer drug delivery. The FA receptor-mediated active targeting and electrostatic interaction between micelles and cell membrane due to a negative-to-positive charge reversal was combined in one micellar anti-cancer drug delivery system to enhance the tumour targeting and cellular internalisation of micelles. In vitro and in vivo anti-cancer studies demonstrated that the doxorubicin-loaded, FA-conjugated and pH-responsive polymeric micelles possess an enhanced and effective cancer efficiency.

Keywords: Cancer therapy; Charge reversal; Drug delivery; FA receptor-mediated active targeting; Micelle; pH-sensitive.

MeSH terms

  • A549 Cells
  • Animals
  • Citric Acid / chemistry
  • Delayed-Action Preparations / chemistry
  • Delayed-Action Preparations / pharmacokinetics
  • Delayed-Action Preparations / pharmacology
  • Doxorubicin* / chemistry
  • Doxorubicin* / pharmacokinetics
  • Doxorubicin* / pharmacology
  • HeLa Cells
  • Hep G2 Cells
  • Humans
  • Hydrogen-Ion Concentration
  • Lactic Acid* / chemistry
  • Lactic Acid* / pharmacokinetics
  • Lactic Acid* / pharmacology
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Micelles*
  • Neoplasms, Experimental / drug therapy*
  • Neoplasms, Experimental / metabolism
  • Neoplasms, Experimental / pathology
  • Polyglycolic Acid* / chemistry
  • Polyglycolic Acid* / pharmacokinetics
  • Polyglycolic Acid* / pharmacology
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Xenograft Model Antitumor Assays

Substances

  • Delayed-Action Preparations
  • Micelles
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polyglycolic Acid
  • Citric Acid
  • Lactic Acid
  • Doxorubicin